Both Br-J-I (10 mg/kg) and positive control metronidazole (MET, 40 mg/kg) suppressed the tumor-promoting effects of Fn and the tumor-inhibitory role of Br-J-I was better than that of MET (Figure 6A,B). The gene discussed is FN1; the disease is neoplasm.